NCT05963087 2023-07-27
Cetuximab in Combination With Dabrafenib and Tislelizumab in BRAF Mutated Treatment of Advanced Colorectal Cancer
Zhejiang Cancer Hospital
Phase NA Not yet recruiting
Zhejiang Cancer Hospital
Zhejiang Cancer Hospital
Fudan University
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente